On Monday, Shares of Cerus Corporation (NASDAQ:CERS), dropped -1.88% to $4.70.
Cerus Corporation, will be presenting at the AABB Symposium on Implementation of Pathogen-Reduced Blood Components taking place in Bethesda, Maryland from April 27 to 28, 2015.
Cerus’ presentation will address the INTERCEPT Blood System recently and its future outlook, counting:
- Current FDA approved label claims for INTERCEPT, counting the ability to reduce transfusion-transmitted infectious risk in apheresis platelet components, and apheresis or whole blood derived plasma components.
- Key potential blood center operational advantages, such as improved platelet availability and reduced component wastage through early platelet release with pathogen reduction.
- Plans to expand claims to comprise a seven-day platelet shelf-life extension, the ability to pathogen reduce whole blood derived platelets, and the development of an INTERCEPT triple set storage kit for improved platelet collection efficiency.
- INTERCEPT red cell system developments, counting the successful completion of US Phase II and European Phase III trials.
Cerus Corporation operates as a biomedical products company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System is based on its proprietary technology for controlling biological replication and designed to target and inactivate blood-borne pathogens, counting viruses, bacteria, and parasites, in addition to potentially harmful white blood cells, while preserving the therapeutic properties of platelet, plasma, and red blood cell transfusion products.
Shares of First American Financial Corporation (NYSE:FAF), declined -1.88% to $37.12, during its last trading session.
First American Financial, declared financial results for the first quarter ended March 31, 2015.
Current Quarter Highlights
- Total revenue of $1.1 billion, up 10 percent contrast with last year
- Direct title orders closed were up 15 percent, driven by a 62 percent enhance in refinance orders
- Average revenue per direct title order closed was up 8 percent
- Title Insurance and Services segment pretax margin of 6.8 percent
- Commercial revenue of $148.5 million, up 28 percent contrast with last year
- Specialty Insurance segment total revenue was up 8 percent, with a pretax margin of 18.2 percent.
Total revenue for the first quarter of 2015 was $1.1 billion, an enhance of 10 percent relative to the first quarter of 2014. Net income in the current quarter was $37.6 million, or 34 cents per diluted share, contrast with net income of $21.7 million, or 20 cents per diluted share, in the first quarter of 2014. Net realized investment gains and losses were immaterial in both the current and preceding periods.
First American Financial Corporation, through its auxiliaries, provides financial services. It operates through Title Insurance and Services, and Specialty Insurance segments. The Title Insurance and Services segment issues title insurance policies on residential and commercial property, in addition to offers related products and services.
At the end of Monday’s trade, Shares of Starbucks Corporation (NASDAQ:SBUX), dwindled -1.87% to $50.87, after the specialty coffee chain’s sales-register system in the U.S. and Canada crashed Friday night.
The company said it was caused by an internal failure, and not from an external breach.
Stores could not accept payments of any kind, forcing some to close while other gave customers free coffee and tea, the Associated Press reports.
The outage affected registers at 7,400 company-operated stores in the U.S. and 1,000 in Canada, according to the AP.
Starbucks Corporation operates as a roaster, marketer, and retailer of specialty coffee worldwide. The company operates in four segments: Americas; Europe, Middle East, and Africa; China/Asia Pacific; and Channel Development. The company’s stores offer coffee and tea beverages, packaged roasted whole bean and ground coffees, single serve products, and juices and bottled water.
Finally, Keysight Technologies, Inc. (NYSE:KEYS), ended its last trade with -1.86% loss, and closed at $34.34.
Keysight Technologies, declared that the EMVCo global technical body has qualified the Keysight T3111S EMV™ Level 1 PICC and Mobile Digital Protocol test suite with the Keysight T1141A Test Set.
This news follows an earlier declaration made by FIME and Keysight in March, when qualification was achieved for the EMV Level 1 RF test suite developed by FIME with the Keysight T1141A Test Set.
The T1141A-based systems now offer the industry one of the most qualified single-platform coverage for Contactless Card and Mobile EMV Level 1 test. Qualification is underway also for existing FIME Analog and Keysight Digital Protocol PCD (Proximity Coupling Device) test suites.
Developers will use the newly qualified test suites for certification test in test laboratories and as the developers prepare their mobiles and contactless card payment devices for certification. The flexible and easy to use T3111S system is used throughout the NFC and contactless payments industry – providing users with key insights and accelerating the development and verification processes.
Keysight Technologies, Inc. provides electronic measurement solutions to the communications and electronics industries in the United States and internationally. It operates through two segments: Measurement Solutions, and Customer Support and Services.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
